Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fulcrum Therapeutics (FULC) Other Non Operating Income (2018 - 2019)

Fulcrum Therapeutics (FULC) has 2 years of Other Non Operating Income data on record, last reported at $7000.0 in Q4 2019.

  • On a quarterly basis, Other Non Operating Income changed 0.0% to $7000.0 in Q4 2019 year-over-year; TTM through Dec 2019 was $29000.0, a N/A change, with the full-year FY2019 number at $29000.0, down 92.6% from a year prior.
  • Other Non Operating Income reached $7000.0 in Q4 2019 per FULC's latest filing, roughly flat from $7000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for FULC hit a ceiling of $8000.0 in Q2 2018 and a floor of $7000.0 in Q3 2018.